Growth Metrics

Anaptysbio (ANAB) Other Working Capital Changes (2016 - 2026)

Anaptysbio posted quarterly Other Working Capital Changes of -$499000.0 for Q1 2026, down 8.01% year-on-year from -$542442.4 in Q1 2025, and down 175.69% on a QoQ basis from -$181000.0 in Q4 2025.

Anaptysbio (ANAB) has 11 years of Other Working Capital Changes data on file, last reported at -$499000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Working Capital Changes fell 8.01% year-over-year to -$499000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.6 million (up 68.48% YoY), and the FY2025 full-year result was -$1.6 million, up 49.67% from the prior year.
  • Other Working Capital Changes for Q1 2026 stood at -$499000.0, down from -$181000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $4.1 million in Q2 2022 and bottomed at -$6.5 million in Q3 2022.
  • The 5-year median for Other Working Capital Changes is -$420000.0 (2023), against an average of -$497352.9.
  • Peak annual rise in Other Working Capital Changes reached 3170.59% in 2024, while the deepest fall reached 288.39% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$389000.0 in 2022, then decreased by 7.97% to -$420000.0 in 2023, then gained by 28.81% to -$299000.0 in 2024, then jumped by 39.46% to -$181000.0 in 2025, then slumped by 175.69% to -$499000.0 in 2026.
  • The last three Other Working Capital Changes figures came in at -$499000.0 (Q1 2026), -$181000.0 (Q4 2025), and -$490000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Anaptysbio 1.60 Bn 1.31 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -499,000.00
Mar 31, 2026 -499,000.00
Dec 31, 2025 -181,000.00
Dec 31, 2025 -181,000.00
Sep 30, 2025 -490,000.00
Sep 30, 2025 -490,000.00
Jun 30, 2025 -479,000.00
Jun 30, 2025 -479,000.00
Mar 31, 2025 -462,000.00
Mar 31, 2025 -462,000.00
Dec 31, 2024 -299,000.00
Dec 31, 2024 -299,000.00
Sep 30, 2024 -2.04 Mn
Sep 30, 2024 -2.04 Mn
Jun 30, 2024 -2.43 Mn
Jun 30, 2024 -2.43 Mn
Mar 31, 2024 1.57 Mn
Mar 31, 2024 1.57 Mn
Dec 31, 2023 -420,000.00
Dec 31, 2023 -420,000.00
Sep 30, 2023 -2.46 Mn
Sep 30, 2023 -2.46 Mn
Jun 30, 2023 1.29 Mn
Jun 30, 2023 1.29 Mn
Mar 31, 2023 -51,000.00
Mar 31, 2023 -51,000.00
Dec 31, 2022 -389,000.00
Dec 31, 2022 -389,000.00
Sep 30, 2022 -6.46 Mn
Sep 30, 2022 -6.46 Mn
Jun 30, 2022 4.12 Mn
Jun 30, 2022 4.12 Mn
Mar 31, 2022 1.22 Mn
Mar 31, 2022 1.22 Mn
Dec 31, 2021 -8.61 Mn
Dec 31, 2021 -8.61 Mn
Sep 30, 2021 5.31 Mn
Sep 30, 2021 5.31 Mn
Jun 30, 2021 3.38 Mn
Jun 30, 2021 3.38 Mn
Mar 31, 2021 -145,000.00
Mar 31, 2021 -145,000.00
Dec 31, 2020 -4.66 Mn
Dec 31, 2020 -4.66 Mn
Sep 30, 2020 3.90 Mn
Sep 30, 2020 3.90 Mn
Jun 30, 2020 -187,000.00
Jun 30, 2020 -187,000.00
Mar 31, 2020 -233,000.00
Mar 31, 2020 -233,000.00
Dec 31, 2019 -1.48 Mn
Dec 31, 2019 -1.48 Mn
Sep 30, 2019 -490,000.00
Sep 30, 2019 -490,000.00
Jun 30, 2019 -2.82 Mn
Jun 30, 2019 -2.82 Mn
Mar 31, 2019 1.22 Mn
Mar 31, 2019 1.22 Mn
Dec 31, 2018 3.79 Mn
Dec 31, 2018 3.79 Mn
Sep 30, 2018 217,000.00
Sep 30, 2018 217,000.00
Jun 30, 2018 1.57 Mn
Jun 30, 2018 1.57 Mn
Mar 31, 2018 -388,000.00
Mar 31, 2018 -388,000.00
Dec 31, 2017 304,000.00
Dec 31, 2017 304,000.00
Sep 30, 2017 -909,000.00
Sep 30, 2017 -909,000.00
Jun 30, 2017 2.35 Mn
Jun 30, 2017 2.35 Mn
Mar 31, 2017 143,000.00
Mar 31, 2017 143,000.00
Dec 31, 2016 2.49 Mn
Dec 31, 2016 2.49 Mn
Sep 30, 2016 -1.79 Mn
Sep 30, 2016 -1.79 Mn
Jun 30, 2016 49,000.00
Jun 30, 2016 49,000.00
Mar 31, 2016 323,000.00
Mar 31, 2016 323,000.00